Celgene (CELG) Profit Margin History
Historical gross, operating and net quarterly profit margin for Celgene (CELG) over the last 10 years. The current net profit margin for Celgene as of November 17, 2017 is 27.36%.
|Medical||Medical - Biomedical and Genetics||$81.960B||$11.229B|
|Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.|